List of articles in "Drug" category - Page 19

O-1918 is a synthetic compound related to cannabidiol which is an antagonist at two former orphan receptors GPR18 and GPR55 that appear to be related to the cannabinoid receptors. O-1918 […]

O-1602 is a synthetic compound most closely related to abnormal cannabidiol and more distantly related in structure to cannabinoid drugs such as THC. O-1602 does not bind to the classical […]

Delamanid (USAN codenamed OPC-67683) is an experimental drug for the treatment of multi-drug-resistant tuberculosis. It works by blocking the synthesis of mycolic acids in Mycobacterium tuberculosis the organism which causes […]

Forasartan otherwise known as the compound SC-52458 is a nonpeptide angiotensin II receptor antagonist (ARB AT1 receptor blocker).

Technetium (99mTc) tilmanocept trade name Lymphoseek is a radiopharmaceutical diagnostic imaging agent approved by the U.S. Food and Drug Administration (FDA) for the imaging of lymph nodes. It is used […]

Deleobuvir (formerly BI 207127) was an experimental drug for the treatment of hepatitis C. It was being developed by Boehringer-Ingelheim. It is a non-nucleoside hepatitis C virus NS5B polymerase inhibitor.

Faldaprevir (formerly BI 201335) is an experimental drug for the treatment of hepatitis C.

Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed by Gilead Sciences. After completing Phase III clinical trials on Feb 10 2014 Gilead filed […]

Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor under development by Merck & Co. for use in the treatment of HIV infection. Doravirine demonstrated robust antiviral activity and good tolerability […]

Andexanet alfa (PRT064445 PRT4445) is a drug under investigation as a potential antidote for factor Xa inhibitors a group of anticoagulant (anti–blood clotting) drugs that includes rivaroxaban apixaban and edoxaban. […]